The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023, a bipartisan insulin affordability bill. Introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME), this legislation would cap out-of-pocket insulin costs for those with private insurance, ensure patients can share in insulin rebates and discounts,...
The Endocrine Society praised the European Food Safety Agency’s (EFSA) decision to establish a strict limit on the amount of bisphenol A (BPA) that can be safely consumed daily. BPA — a chemical that mimics the effects of estrogen on the body — seeps into food and drinks through plastics and other packaging. BPA has...
The popularity of GLP-1 agonists to treat obesity has been skyrocketing in recent months, leading to both shortages and price increases. However, as more patients make their voices heard and doctors begin to prescribe them, obesity could become easier to treat or even cure. Thanksgiving is a time for family, fellowship, and food. But for...
I’m so proud of the news presence the Society has built and the coverage we have had over the last few months related to our Obesity Science Writers Conference and our advocacy efforts. We are regularly featured in the news for our research and advocacy. Reporters rely on our members’ expertise on various endocrine health...
We are pleased to report the Centers for Medicare & Medicaid Services (CMS) finalized policy that will expand coverage of Continuous Glucose Monitors (CGM) and incorporated Endocrine Society recommendations. The final local coverage determination (LCD) expands CGM coverage for all people with diabetes with any type or manner of insulin treatment. The policy also will...
Last month, three of the largest insulin manufacturers announced they would take steps to reduce the price of their insulins. Eli Lilly and Company first announced it would reduce the list price for certain insulins by 70% and extend the $35 per month cap on out-of-pocket costs for people with Medicare that was enacted in...
Obesity is a public health crisis in the United States. As a prevalent and costly disease, it puts adults and children at risk for many comorbid conditions, reduces productivity, and impairs military readiness. As the 118th Congress gets underway, several congressional leaders and committees are interested in addressing obesity in America. In March, as part...
The U.S. Environmental Protection Agency (EPA) issued a landmark regulation to set exposure limits for several per- and polyfluoroalkyl substances (PFAS) substances including PFOS and PFOAS found in drinking water. The proposed regulation sets an aggressive limit for these PFAS and their mixtures and acknowledges effects at extremely low levels by proposing a health-based Maximum...
I’m so proud of the news presence the Society has built and the coverage we have had over the last few months related to our Obesity Science Writers Conference and our advocacy efforts. We are regularly featured in the news for our research and advocacy. Reporters rely on our members’ expertise on various endocrine health...